Join AVBCC on X (formerly Twitter)

Home
Issues
Browse By Topic
Conference Correspondent
- SABCS 2023 - HER2+ MBC
- ASCO 2023 - Breast Cancer
Web Exclusives
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma

Mechanism of Pathway: The Promise of PD-1 Pathway Blockade in the Treatment of Metastatic Cancer

View the Latest Issue of VBCC

View the Latest Issue

Top Trending Articles

1.

Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS

2.

New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors

3.

Bringing Stakeholders Together Bringing Stakeholders Together

Home
Issues
Browse By Topic
Conference Correspondent
- SABCS 2023 - HER2+ MBC
- ASCO 2023 - Breast Cancer
Web Exclusives
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

About
About VBCC
Mission Statement
Editorial Advisory Board
Advertising
Contact

Contribute
Submit a Manuscript
Editorial / Publishing Policies
Author Guidelines

Publications
Value-Based Cancer Care
Value-Based Care in Myeloma
Cholangiocarcinoma News

© Association for Value-Based Cancer Care (AVBCC)®. All Rights Reserved. Privacy Policy.